VictorHugoG.Johnson (@vikouermd) 's Twitter Profile
VictorHugoG.Johnson

@vikouermd

Attending Nephrologist @NefrologiaINC | Cardiorenal | Critical Care Nephrology @UAB_NRTC | POCUS | Music Lover | Calisthenics

ID: 99389872

calendar_today26-12-2009 00:45:24

5,5K Tweet

717 Followers

436 Following

Aravind Palraj (@rheumat_aravind) 's Twitter Profile Photo

🧵 ANCA in Rheumatology: Tweet 1: ANCA — one antibody, many confusions. From GPA to drug-induced vasculitis, it’s powerful when used right… and misleading when used wrong. Here’s a quick guide 👇 Dr Ihab Suliman Dr. Akhil 🇮🇳 Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪 #MedTwitter #Rheumatology

🧵 ANCA in Rheumatology:

Tweet 1:
ANCA — one antibody, many confusions.
From GPA to drug-induced vasculitis, it’s powerful when used right…
and misleading when used wrong.
Here’s a quick guide 👇
<a href="/IhabFathiSulima/">Dr Ihab Suliman</a> <a href="/DrAkhilX/">Dr. Akhil 🇮🇳</a> <a href="/CelestinoGutirr/">Dr Celestino Gutiérrez González MD 🇪🇸🍏🇻🇪</a> #MedTwitter #Rheumatology
Brendon Neuen (@brendonneuen) 's Twitter Profile Photo

Do we have it the wrong way around? Reduced GFR is cited as a reason to defer simultaneous initiation of #kidneyGDMT due to potential impact of acute 🔽 in GFR - but randomised data indicate diminished acute "dips" at lower GFR for RASi, SGLT2i & combo SGLT2/nsMRA Muthu Vaduganathan

Do we have it the wrong way around?

Reduced GFR is cited as a reason to defer simultaneous initiation of #kidneyGDMT due to potential impact of acute 🔽 in GFR - but randomised data indicate diminished acute "dips" at lower GFR for RASi, SGLT2i &amp; combo SGLT2/nsMRA <a href="/mvaduganathan/">Muthu Vaduganathan</a>
Diego Segura-Rodríguez (@seguracardio) 's Twitter Profile Photo

✨Súper herramienta para ajustar la dosis del tratamiento antihipertensivo según: -Su potencia - mmHg deseados de bajada bpmodel.org #HTA #HTN #Hypertension

SLANH (@slanh_) 's Twitter Profile Photo

✅ PROGRAMA EDUCATIVO ANUAL DIALOGANDO CON EXPERTOS 👉 Lanzamiento del Comité Cardiorenal 🚀 Tema: UCR en latinoamerica: una realidad posible. 🗓️ Miércoles 10 septiembre 2025 🕖 19:00 Hs: 🇵🇦 PA ✅ REGISTRATE AQUI: bit.ly/slanh10septiem… 🌐 slanh.net

✅ PROGRAMA EDUCATIVO ANUAL DIALOGANDO CON EXPERTOS 

👉 Lanzamiento del Comité Cardiorenal

🚀 Tema: UCR en latinoamerica: una realidad posible.

🗓️ Miércoles 10 septiembre 2025
🕖 19:00 Hs: 🇵🇦 PA

✅ REGISTRATE AQUI: bit.ly/slanh10septiem…

🌐 slanh.net
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

A beautiful "explainer" of everything a cardiologist needs to know about #eGFR in HF clinical practice with modern #GDMT ...and a plug to bring back #eGFRslope as an endpoint in HF clinical trials New in #EHJ with leading nephrologists Brendon Neuen academic.oup.com/eurheartj/adva…

A beautiful "explainer" of everything a cardiologist needs to know about #eGFR in HF clinical practice with modern #GDMT

...and a plug to bring back #eGFRslope as an endpoint in HF clinical trials

New in #EHJ with leading nephrologists <a href="/brendonneuen/">Brendon Neuen</a>
academic.oup.com/eurheartj/adva…
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

Outpatient Worsening HF (Oral Diuretic Intensification) ☑️ Frequent ☑️ Prognostically meaningful ☑️ Temporally precedes 🏥 ☑️ Similar treatment effect sizes #GDMT as those on 🏥 Building evidence for its role in broader composite esp in lower-risk CKM pts academic.oup.com/eurheartj/arti…

Outpatient Worsening HF (Oral Diuretic Intensification)
☑️ Frequent
☑️ Prognostically meaningful
☑️ Temporally precedes 🏥
☑️ Similar treatment effect sizes #GDMT as those on 🏥

Building evidence for its role in broader composite esp in lower-risk CKM pts
academic.oup.com/eurheartj/arti…
rajkmd (@rajkmd) 's Twitter Profile Photo

My sense is that fewer HF patients will need loop diuretics in the future. I remember a decade ago arguing with a cardiology colleague whose approach was optimizing diuretics and sending patients for thoracentesis. He dismissed GDMT as pharma-driven polypharmacy. Today, many of

Nephrology | Karger (@nephrokarger) 's Twitter Profile Photo

Sodium Retention in Liver #Disease: Is ENaC Activation Independent of the Renin-Angiotensin-Aldosterone System a Therapeutic Target? 🔗ow.ly/GobO50WxO3t ✍ Batlle D. et al. 📖#Nephron #SodiumRetention #Aldosterone

Sodium Retention in Liver #Disease: Is ENaC Activation Independent of the Renin-Angiotensin-Aldosterone System a Therapeutic Target?
🔗ow.ly/GobO50WxO3t
✍ Batlle D. et al. 
📖#Nephron 
#SodiumRetention #Aldosterone
Gregg Fonarow MD (@gcfmd) 's Twitter Profile Photo

Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep Score | Circulation: Heart Failure ahajournals.org/doi/full/10.11… Steve Greene

Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

2025 HF RCT Landscape 💊💉 HFpEF GLP1/GIP: #MARITIME sMRA: #SPIRRIT #SPIRITHF nsMRA: #REDEFINE ASi: #EASiHFPreserved IL6i: #HERMES HFrEF nsMRA: #FINALITY ASi: #EASiHFReduced Myosin Activator: #COMET Dig: #DECISION IV Fe: #ICONICHF All LVEF nsMRA: #CONFIRMATION MRmod: #BalanceD

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨 Oral Semaglutide 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - - - Just out in NEJM: A 71-week RCT tested oral semaglutide 25 mg daily in adults with overweight/obesity (no diabetes). 📊 Results at 64 weeks: 🔹−13.6% mean weight loss vs. −2.2% with

🚨 Oral Semaglutide 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial)
- - -
Just out in <a href="/NEJM/">NEJM</a>: A 71-week RCT tested oral semaglutide 25 mg daily in adults with overweight/obesity (no diabetes).

📊 Results at 64 weeks:
🔹−13.6% mean weight loss vs. −2.2% with
NDT (@ndtsocial) 's Twitter Profile Photo

Optimal glucocorticoid therapy in lupus nephritis 🔓doi.org/10.1093/ndt/gf… ➡️This review provides an in-depth analysis of glucocorticoid therapy for lupus nephritis, a severe manifestation of systemic lupus erythematosus that affects up to 51.7% of patients

Optimal glucocorticoid therapy in lupus nephritis

🔓doi.org/10.1093/ndt/gf…

➡️This review provides an in-depth analysis of glucocorticoid therapy for lupus nephritis, a severe manifestation of systemic lupus erythematosus that affects up to 51.7% of patients
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

Glomerular filtration rate (GFR) is more than a biomarker! yes, it’s playful & dances in response to therapies but it is a direct reflection of kidney function its decline is a necessary intermediate to kidney failure thus is considered by regulators as an acceptable endpoint

Glomerular filtration rate (GFR) is more than a biomarker!

yes, it’s playful &amp; dances in response to therapies

but it is a direct reflection of kidney function

its decline is a necessary intermediate to kidney failure

thus is considered by regulators as an acceptable endpoint
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

New in European Society of Cardiology #EHJ Original article from #EPHESUS #EMPHASIS #BARCELONA studies 🔗 academic.oup.com/eurheartj/adva… Editorial with Brendon Neuen 🔗 academic.oup.com/eurheartj/adva…

New in <a href="/escardio/">European Society of Cardiology</a> #EHJ 

Original article from #EPHESUS #EMPHASIS #BARCELONA studies
🔗 academic.oup.com/eurheartj/adva…

Editorial with <a href="/brendonneuen/">Brendon Neuen</a> 
🔗 academic.oup.com/eurheartj/adva…
Dr.Mukesh , MD , DM (@dr_immuno29) 's Twitter Profile Photo

⚡️ Glucocorticoid-Induced Osteoporosis (GIOP): 2025 Update ⚡️ •💊 Most common drug-induced osteoporosis → affects 30–50% of chronic GC users. •⏱️ Fracture risk rises in 3–6 months of therapy; risk not fully reversible post-discontinuation. •⚠️ Even low-dose pred (≥2.5

⚡️ Glucocorticoid-Induced Osteoporosis (GIOP): 2025 Update ⚡️
•💊 Most common drug-induced osteoporosis → affects 30–50% of chronic GC users.
•⏱️ Fracture risk rises in 3–6 months of therapy; risk not fully reversible post-discontinuation.
•⚠️ Even low-dose pred (≥2.5